… of the biotechnology industry, dynamic capabilities theory is a … firm's product development
capabilities in the biotechnology … capabilities is more uncertain in small biotechnology firms …

… Consequently, in this study, we focused on the biologics of medical biotechnology and
used multinational enterprises in China, Australia, and India as the study subjects. …

… biotechnology was a novel approach to drug synthesis, just about every biotechnology firm
… the challenge of developing a novel set of capabilities early in their lives. Whereas product …

… and innovative capabilities) dynamic capabilities on sustainability … of public and private
biotechnology companies in the United … capabilities, adaptive capabilities, innovative capabilities, …

… concept of dynamic capabilities. In … dynamic capabilities, we test the opposite predictions
using data from a sample of pharmaceutical firms and their development of biotech capabilities …

… dynamic capabilities, and then identify three component factors which reflect the common
features of dynamic capabilities across firms … and consequences of dynamic capabilities in an …

… For example, the CEO of a major biotech firm told one of the authors, ‘We have the best
research process in the industry, but we don’t know why.’ Further, many managers have a …

… property, technologies, marketing and production capabilities, today's competitive environment
is … firms have avoided a reliance on external expertise in the face of new biotechnological …

… performance of Mexican biotechnology firm according to their capabilities of innovation, …
from a national survey of biotechnology firms in 2015. Biotechnology firms were adopted as the …

… (1998) followed this study up with a study showing that knowledge spills over from universities
to biotech firms located near universities, and this tacit knowledge is a large source of …